Moderators of treatment effect in a randomised controlled trial of single‐ and multi‐family therapy for anorexia nervosa in adolescents and emerging adults
European Eating Disorders Review · 2026
DOI: 10.1002/erv.3050 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Eating Disorders Review, 2026. Verfasst von Julian Baudinet und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Hauptthemen laut MEDLINE: Anorexia Nervosa, Family Therapy. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
Introduction
Multi‐family therapy for anorexia nervosa (MFT‐AN) is a novel, group‐based intervention that intensifies single‐family therapy for anorexia nervosa (FT‐AN), with the aim of improving outcomes. The current study explored treatment moderators in a randomised controlled trial ( N = 167) of FT‐AN and MFT‐AN for young people (adolescents/emerging adults aged 13–20 years) with anorexia nervosa.
Methods
Data were analysed using multiple linear regression. Six hypothesised baseline participant and parent factors were tested as possible moderators of treatment effect on end‐of‐treatment and follow‐up percentage of median Body Mass Index (%mBMI); age, eating disorder symptom severity, perceived family conflict (young person and parent ratings) and parent‐rated experiences of caregiving (positive and negative).
Results
Greater parent‐rated positive caregiving experiences moderated treatment outcomes at follow‐up ( β = −0.47, 95%CI: −0.91, −0.03, p = 0.04), but not end‐of‐treatment. Participants who had fewer parent‐rated positive caregiving experiences at baseline had higher weight at follow‐up if they had MFT‐AN compared to FT‐AN. No other hypothesised baseline factors moderated treatment outcome ( p 's > 0.05).
Discussion
The current study suggests MFT‐AN may be indicated for families who present with fewer positive caregiving experiences to treatment. The MFT‐AN group context may help to promote mentalisation and hope for these families, which may be harder to achieve in single‐family treatment. Future research is needed to empirically evaluate how and why MFT‐AN supports this group more. Trial Registration ISRCTN registry: ISRCTN11275465, registered 29 January 2007.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Research in Eating and Weight Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
- Maudsley Centre for Child and Adolescent Eating Disorders, South London and Maudsley NHS Foundation Trust, London, UK.
- Department of Biostatistics and Health Informatics, School of Mental Health and Psychological Sciences, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
- Adult Eating Disorders Service, South London and Maudsley NHS Foundation Trust, London, UK.
ORCID-Profile: Julian Baudinet, John Hodsoll, Ulrike Schmidt, Mima Simic, Sabine Landau, Ivan Eisler
Förderung
- Medical Research Council
Zitieren
APA
Baudinet, J., Hodsoll, J., Schmidt, U., Simic, M., Landau, S., & Eisler, I. (2026). Moderators of treatment effect in a randomised controlled trial of single‐ and multi‐family therapy for anorexia nervosa in adolescents and emerging adults. European Eating Disorders Review. https://doi.org/10.1002/erv.3050
Vancouver
Baudinet J, Hodsoll J, Schmidt U, Simic M, Landau S, Eisler I. Moderators of treatment effect in a randomised controlled trial of single‐ and multi‐family therapy for anorexia nervosa in adolescents and emerging adults. European Eating Disorders Review. 2026. doi:10.1002/erv.3050
BibTeX
@article{Baudinet2026,
author = {Baudinet, Julian and Hodsoll, John and Schmidt, Ulrike and Simic, Mima and Landau, Sabine and Eisler, Ivan},
title = {Moderators of treatment effect in a randomised controlled trial of single‐ and multi‐family therapy for anorexia nervosa in adolescents and emerging adults},
journal = {European Eating Disorders Review},
year = {2026},
doi = {10.1002/erv.3050}
}
EUVIMED